Quantification of HIV-1 viral load in lymphoid and blood cells: Assessment during four-drug combination therapy

AIDS

Volumn 11, Issue 7, 1997, Pages 895-901

  Tamalet, Catherine ^a   Lafeuillade, Alain ^b   Fantini, Jacques ^c   Poggi, Cécile ^b   Yahi, Nouara ^a  

^a TIMONE HOSPITAL   (France)

^b GENERAL HOSPITAL   (France)

^c CNRS   (France)

Author keywords

AIDS; Antiviral therapy; Didanosine; HIV; Lamivudine; Lymph nodes; Saquinavir; Viral load; Zidovudine

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; LAMIVUDINE; SAQUINAVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPH NODE CELL; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DIDANOSINE; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; SAQUINAVIR; VIRAL LOAD; VIREMIA; ZIDOVUDINE;

EID: 0030962940     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199707000-00009     Document Type: Article

References (25)

1. O'Brien WA, Hartigan PM, Martin D, et al.: Changes in plasma HIV-1 RNA and CD4+ lymphocytes counts and the risk of progression to AIDS. N Engl J Med 1996, 334:426-431.
2. Katzenstein DA, Hammer SM, Hughes MD, et al.: The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-1 infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996, 335:1091-1098.
3. Gulick R, Mellors J, Havlir D, et al.: Potent and sustained anti-retroviral activity of indinavir in combination with zidovudine and lamivudine. 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract L.B7].
4. Massari F, Conant M, Mellors J, et al.: A Phase II open label randomized study of the triple combination of indinavir alone, zidovudine and didanosine versus indinavir alone and zidovudine/didanosine in antiretroviral naive patients, 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract 200].
5. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
6. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
7. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
8. Lafeuillade A, Poggi C, Profizi N, Tamalet C, Costes O: Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. J Infect Dis 1996, 174:407-410.
9. Manouilov KK, White CA, Boudinot FD, et al.: Lymphatic distribution of 3′-azido-3′-deoxythymidine and 3′-azido-2′3′ dideoxyuridine in mice. Drug Metab Dispos 1995, 23:655-658.
10. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
11. Pantaleo G, Graziosi C, Demarest JF, et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358.
12. Embrelson J, Zupancic M, Ribas I. et al.: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362.
13. Haase AT, Henry K, Zupancic M, et al.: Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996. 274:985-989.
14. Merrill DP, Moonis M, Chou TC, Hirsch MS: Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J Infect Dis 1996, 173:355-364.
15. Collier AC, Coombs RW, Schoenfeld DA, et al.: Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl I Med 1996, 334:1011-1017.
16. Noble S, Faulds D: Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection. Drugs 1996, 52:93-112.
17. Rouzioux C, Puel J, Agut H, et al.: Comparative assessment of quantitative HIV viraemia assays. AIDS 1992, 6:373-377.
18. Izopet J, Marchou B, Sandres K, et al.: HIV-1 proviral DNA and RNA dynamics after initiating AZT+ddC combination therapy. 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC, January-February 1996 [abstract 296].
19. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994, 32:292-300.
20. Gupta P, Kingsley L, Armstrong J, et al.: Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993, 196:586-595.
21. Cohen OJ, Pantaleo G, Holodny M, et al.: Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. J Infect Dis 1996, 173:849-856.
22. Cohen OJ, Pantaleo G, Holodny M, et al.: Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci USA 1995, 82:6017-6021.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
24. Lafeuillade A, Tamalet C, Poggi C, Pellegrino P, Tourres C, Izopet J: Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes. AIDS 1997, 11:67-72
25. Ho DD: Time to hit HIV, early and hard. N Engl J Med 1995, 333:450-451.